Dr. Sergey G. Gurevich, MD

Dr. Gurevich practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Gurevich's NPI, 1578839015, was assigned on March 29, 2012. Dr. Gurevich graduated from Medical College of Wisconsin in 2012. Dr. Gurevich holds Minnesota license 60755.

Dr. Gurevich's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Gurevich's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Gurevich to 9 more medical groups, 6 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gurevich practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gurevich's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gurevich is licensed in Minnesota.

CMS data shows 434 Medicare services from Dr. Gurevich across 12 procedure codes in 2024, for 208 Medicare patients. Medicare paid $45,790 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 208 Medicare patients who saw Dr. Gurevich in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gurevich's median patient age at 69, with 37% women.

In 2024, Dr. Gurevich wrote 740 Medicare Part D claims for 129 patients. 84% of them were for generic drugs. CMS names the drug for 649 of them, across 17 drugs with 11 or more claims each, at $86,320 in total drug cost. In 2023, CMS named 718 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gurevich for performance year 2024, reported as part of a group. Dr. Gurevich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of coronary angioplasty and stenting by Dr. Gurevich, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 25 papers to Dr. Gurevich, published from 2014 to 2024. 2024 was the busiest year, with 7. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve and Aortic Valve Stenosis. Dr. Gurevich has published most often in Cardiovasc Revasc Med. Dr. Gurevich's most frequent co-authors are Rosemary Frances Kelly, MD, Jason Alan Bartos, MD and Brett A. Oestreich, MD.

CMS Open Payments shows 104 general payments to Dr. Gurevich from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 38% of the total. Boston Scientific Corporation paid the most, $4,648.

Dr. Gurevich graduated from Medical College of Wisconsin in 2012.